Bolt Biotherapeutics: Jumps in market debut
05/02/2021 16:53
** Shares of Bolt Biotherapeutics BOLT.O jump more than
30% to $26.1 in their Nasdaq debut
** At the debut price, co was valued at nearly $875 mln
** Co's IPO was priced at $20 per share urn:newsml:reuters.com:*:nGNX7tbD4P
** Bolt offered 11.5 mln shares in IPO, raising about $230
mln
** Co is a clinical-stage immuno-oncology company that
develops therapies that target tumors
** Morgan Stanley, SVB Leerink, Stifel and Guggenheim
Securities were the joint bookrunners for the offering
(Reporting by Sohini Podder in Bengaluru)
((sohini.podder@thomsonreuters.com))